Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$784M |
| 2 |
Apple
AAPL
|
+$427M |
| 3 |
Danaher
DHR
|
+$417M |
| 4 |
Prologis
PLD
|
+$405M |
| 5 |
Amazon
AMZN
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$587M |
| 2 |
Eli Lilly
LLY
|
+$491M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$343M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$252M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Algoma Steel
ASTL
$461M
| $929K | ﹤0.01% |
131,034
-36,971
| -22% | -$243K |
|
3377
Ovid Therapeutics
OVID
$485M
| $929K | ﹤0.01% |
499,635
+7,562
| +2% | +$12.9K |
|
|
BLU
3378
DELISTED
BELLUS Health Inc.
BLU
| $929K | ﹤0.01% |
113,260
| – | – |
|
3379
Foster
FSTR
$414M
| $924K | ﹤0.01% |
95,511
+901
| +1% | +$9.13K |
|
3380
Lee Enterprises
LEE
$181M
| $920K | ﹤0.01% |
49,605
+564
| +1% | +$10.2K |
|
3381
Stereotaxis
STXS
$142M
| $920K | ﹤0.01% |
444,787
+4,917
| +1% | +$9.61K |
|
|
CD
3382
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $920K | ﹤0.01% |
115,528
-20,361
| -15% | -$143K |
|
|
AGFS
3383
DELISTED
AgroFresh Solutions Inc
AGFS
| $919K | ﹤0.01% |
310,568
+104,754
| +51% | +$263K |
|
3384
Sensus Healthcare
SRTS
$50.4M
| $912K | ﹤0.01% |
122,917
+1,214
| +1% | +$10.9K |
|
3385
ProKidney
PROK
$341M
| $911K | ﹤0.01% |
132,808
+30,253
| +29% | +$289K |
|
3386
INmune Bio
INMB
$58M
| $906K | ﹤0.01% |
142,997
+3,391
| +2% | +$24.1K |
|
3387
Escalade
ESCA
$298M
| $905K | ﹤0.01% |
88,917
-208
| -0.2% | -$2.16K |
|
3388
Citizens
CIA
$196M
| $902K | ﹤0.01% |
423,696
+4,403
| +1% | +$12.3K |
|
3389
Matinas BioPharma
MTNB
$1.7M
| $902K | ﹤0.01% |
36,097
+2,293
| +7% | +$76.3K |
|
3390
J. Jill
JILL
$275M
| $901K | ﹤0.01% |
36,363
+3,007
| +9% | +$66.5K |
|
3391
Acumen Pharmaceuticals
ABOS
$176M
| $900K | ﹤0.01% |
166,820
+9,175
| +6% | +$61.6K |
|
3392
Cue Biopharma
CUE
$116M
| $900K | ﹤0.01% |
10,528
+574
| +6% | +$52.5K |
|
3393
Twin Disc
TWIN
$348M
| $899K | ﹤0.01% |
92,589
+1,165
| +1% | +$12.3K |
|
3394
CEL-SCI Corp
CVM
$30.1M
| $897K | ﹤0.01% |
12,737
+135
| +1% | +$11.9K |
|
|
EIGR
3395
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $897K | ﹤0.01% |
25,344
+761
| +3% | +$91.4K |
|
3396
MediciNova
MNOV
$66M
| $896K | ﹤0.01% |
437,247
+4,374
| +1% | +$9.66K |
|
|
LYLT
3397
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $896K | ﹤0.01% |
371,894
+24,815
| +7% | +$42.5K |
|
3398
ICICI Bank
IBN
$107B
| $895K | ﹤0.01% |
40,923
| – | – |
|
3399
Red Robin
RRGB
$152M
| $894K | ﹤0.01% |
160,322
+1,450
| +0.9% | +$10.8K |
|
|
SFBC
3400
Sound Financial Bancorp
SFBC
$110M
| $894K | ﹤0.01% |
22,100
-48
| -0.2% | -$1.93K |
|
Similar funds
Geode Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Geode Capital Management held 5,090 positions worth $713B, up 8.1% from $659B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 4.9%. Geode Capital Management opened 62 new positions and exited 188, leaving the 5,090-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2022 buy was Ferguson: 1,854,192 shares worth $235M.
- Geode Capital Management added most to Microsoft in Q4 2022, an estimated $784M increase.
- Geode Capital Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $491M.
- Geode Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $587M.
- Geode Capital Management's ten largest holdings make up 20% of its $713B portfolio in Q4 2022.
- Geode Capital Management opened 62 new positions and closed 188 in Q4 2022.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $713B.
Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.